The impact of PD-1 inhibitors on prognosis in unresectable hepatocellular carcinoma treated with TACE and lenvatinib: a retrospective study

Abstract Our aim was to explore whether programmed death receptor-1 (PD-1) inhibitors would improve the prognosis of unresectable hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE) plus lenvatinib. In this single-center retrospective study, patients with unresectable...

Full description

Bibliographic Details
Published in:Scientific Reports
Main Authors: Zongren Ding, Guoxu Fang, Yanyan Tang, Yongyi Zeng
Format: Article
Language:English
Published: Nature Portfolio 2024-06-01
Subjects:
Hepatocellular carcinoma
Transarterial chemoembolization
Lenvatinib
PD-1 inhibitors
Online Access:https://doi.org/10.1038/s41598-024-63571-1

Internet

https://doi.org/10.1038/s41598-024-63571-1

Similar Items